{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-26-000073","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2026-10-21T10:15:14+00:00","discovered_at":"2026-10-21T10:20:00.308513+00:00","generated_at":"2026-10-21T10:20:06.361674+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Integra Q3 revenue $411.2M (+2.3%), adjusted EPS $0.59; Q4 guide implies revenue decline","bullets":["Revenue $411.2M, up 2.3% reported and 2.5% organic, including ~$7M hit from Cincinnati flood damage; GAAP EPS $0.19 vs $(0.07), adjusted EPS $0.59 vs $0.54.","Specialty Surgery revenue $304.1M (+3.9% reported, +4.2% organic) with Neuro +6.5% organic, Instruments -0.9%, ENT -1.1%; Tissue Reconstruction $107.1M, down 2.2% organic.","Adjusted gross margin 61.1% vs 62.9%; adjusted EBITDA $79.8M (19.4% of revenue) vs $78.5M; operating cash flow $96.0M; net debt $1.5B; total leverage 3.8x.","Oct 19 closed $2.1B refinancing: $1.65B credit facility ($600M Term Loan A, $600M revolver, $450M Term Loan B) plus $450M 9.5% notes due 2033; 2027 leverage covenant eased to 4.25x from 4.0x.","Q4 guide: revenue $413-433M (-5.2% to -0.5%) and adjusted EPS $0.61-0.71; FY26 revenue $1.634-1.654B, adjusted EPS $2.30-2.40, cash flow ~$190-200M, unchanged from Oct 2."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-26-000073","json":"https://secwatch.observer/filing/0000917520-26-000073.json","markdown":"https://secwatch.observer/filing/0000917520-26-000073.md","text":"https://secwatch.observer/filing/0000917520-26-000073.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000073/0000917520-26-000073-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000073/iart-20261021.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-21T10:20:06.361674+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}